Apretude

HIV Prevention: Apretude, the First Injectable Drug That Can Replace Daily Pill Now FDA Approved

Medicine & Technology Dec 23, 2021

The FDA announced its approval of the first injectable human immunodeficiency virus (HIV) prevention treatment called Apretude for use in at-risk individuals both adults and children.

Apretude

HIV Prevention: Apretude, the First Injectable Drug That Can Replace Daily Pill Now FDA Approved

Most Popular

Anavex Life Sciences Alzheimer's Treatment Brings Hope to Millions

Cave of Death in Costa Rica Appears Harmless but Can Instantly Kill Anyone at the Entrance

The AI Revolution in Investment Management

Cruise Ship Finds 50,000-Pound Dead Sei Whale; Investigations Suggest That Endangered Species Could Have Died After Being Struck by the Vessel

Space Weather Alert: NOAA Warns of a Solar Radiation Storm With 60% Chance of Hitting the Earth This Week

Recommended Stories

Helium Leak Delays Boeing’s Astronaut Launch Attempt for the Second Time; Crew Debut Set on May 21 After Spacecraft Repair

Bizarre Planet 'WASP-193b' Found To Have the Density of Cotton Candy Despite Its Enormous Size, Making It Second-Least Dense Exoplanet Ever Discovered

US Space Force Orders $414M Advanced Missile Defense Satellites To Track Hypersonic Threats

SpaceX’s Starship Megarocket Prepares for Next Test Flight in 3–5 Weeks, Confirms Elon Musk